Adagio Medical Holdings, Inc. Research And Development Expense

Quick Answer

Adagio Medical Holdings, Inc. reported Research And Development Expense of $10.64 million for the year ending 2025.

  • Adagio Medical Holdings, Inc. showed a decrease of -30.9% in Research And Development Expense from 2023 to 2025.
  • This data is from Adagio Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $10.64 million | Fiscal year 2023: $15.40 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: